These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection. Ray A; Ray S; George AT; Swaminathan N Cochrane Database Syst Rev; 2011 Aug; (8):CD008739. PubMed ID: 21833970 [TBL] [Abstract][Full Text] [Related]
7. Genotyping and Persistence of Candida albicans from Pregnant Women with Vulvovaginal Candidiasis. Tapia CV; Hermosilla G; Fortes P; Alburquenque C; Bucarey S; Salinas H; Rodas PI; Díaz MC; Magne F Mycopathologia; 2017 Apr; 182(3-4):339-347. PubMed ID: 27882525 [TBL] [Abstract][Full Text] [Related]
9. Treatment of vulvovaginal candidiasis: a review of the literature. Dovnik A; Golle A; Novak D; Arko D; Takač I Acta Dermatovenerol Alp Pannonica Adriat; 2015; 24(1):5-7. PubMed ID: 25770305 [TBL] [Abstract][Full Text] [Related]
10. Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines. Nyirjesy P; Brookhart C; Lazenby G; Schwebke J; Sobel JD Clin Infect Dis; 2022 Apr; 74(Suppl_2):S162-S168. PubMed ID: 35416967 [TBL] [Abstract][Full Text] [Related]
11. Vulvovaginal candidiasis: a comparison of HIV-positive and -negative women. Sobel JD Int J STD AIDS; 2002 Jun; 13(6):358-62. PubMed ID: 12015006 [TBL] [Abstract][Full Text] [Related]
12. Is there a role for fluconazole in the treatment of vulvovaginal candidiasis? Patel HS; Peters MD; Smith CL Ann Pharmacother; 1992 Mar; 26(3):350-3. PubMed ID: 1554957 [TBL] [Abstract][Full Text] [Related]
13. Controversial aspects in the management of vulvovaginal candidiasis. Sobel JD J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S10-3. PubMed ID: 8077494 [TBL] [Abstract][Full Text] [Related]
14. Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol. Lírio J; Giraldo PC; Amaral RL; Sarmento ACA; Costa APF; Gonçalves AK BMJ Open; 2019 May; 9(5):e027489. PubMed ID: 31122991 [TBL] [Abstract][Full Text] [Related]
15. Topical antifungal agents. Ernest JM Obstet Gynecol Clin North Am; 1992 Sep; 19(3):587-607. PubMed ID: 1436934 [TBL] [Abstract][Full Text] [Related]
16. The Relationship Between Vulvovaginal Candidiasis and Provoked Vulvodynia: A Systematic Review. Leusink P; van de Pasch S; Teunissen D; Laan ET; Lagro-Janssen AL J Sex Med; 2018 Sep; 15(9):1310-1321. PubMed ID: 30145093 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of acute and recurrent vulvovaginal candidiasis (VVC/rVVC)--state of art in 2008. Expert Board of Polish Gynecological Society]. Kotarski J; Drews K; Maleszka R; Rechberger T; Woroń J; Tomaszewski J; Ginekol Pol; 2008 Sep; 79(9):638-52. PubMed ID: 18939517 [TBL] [Abstract][Full Text] [Related]
18. Recurrent vulvovaginal candidiasis: A review of guideline recommendations. Matheson A; Mazza D Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):139-145. PubMed ID: 28299777 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive review of conventional and non-conventional methods of management of recurrent vulvovaginal candidiasis. Watson C; Calabretto H Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):262-72. PubMed ID: 17627679 [TBL] [Abstract][Full Text] [Related]
20. Chronic vaginal candidiasis. Management in the postmenopausal patient. Nwokolo NC; Boag FC Drugs Aging; 2000 May; 16(5):335-9. PubMed ID: 10917071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]